Wanted to point out that there is +25% jump in assessments in the cumulative assessments from Q4-22 into Q1-23... 2.0m vs 2.5m.
This is +500K assessments (Linkedin post) in the latest quarter vs historical of ~ +300K per quarter.. if anything this is suggesting clinical pull through... which is probably a leading indicator of product acceptance and change in industry behaviour...
PainChek General Discussion, page-20318
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.43M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $78.18K | 1.972M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1006631 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 385241 | 3 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PCK (ASX) Chart |